BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

524238

GUJINJEC

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GUJARAT INJECT (KERALA) LTD. Share Price Update

As of the latest trading session, GUJARAT INJECT (KERALA) LTD. share price is currently at ₹ 20.98, which is down by ₹ -0.77 from its previous closing. Today, the stock has fluctuated between ₹ 20.10 and ₹ 22.88. Over the past year, GUJARAT INJECT (KERALA) LTD. has achieved a return of 31.20 %. In the last month alone, the return has been -18.83 %. Read More...

GUJARAT INJECT (KERALA) LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    30.70

  • P/E Ratio (TTM)

    31.31

  • Beta

    -0.19

  • Book Value / share

    6.65

  • Return on equity

    0.62%

  • EPS (TTM)

    0.67

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.21

info icon alternate text

GUJARAT INJECT (KERALA) LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 3.15
Operating Expense 2.87
Net Profit 0.21
Net Profit Margin (%) 6.66
Earnings Per Share (EPS) 0.14
EBITDA 0.28
Effective Tax Rate (%) 25.00
Particulars SEP 2024 (Values in Cr)
Revenue 8.61
Operating Expense 8.07
Net Profit 0.61
Net Profit Margin (%) 7.08
Earnings Per Share (EPS) 0.42
EBITDA 0.71
Effective Tax Rate (%) 14.08
Particulars JUN 2024 (Values in Cr)
Revenue 3.05
Operating Expense 2.88
Net Profit 0.12
Net Profit Margin (%) 3.93
Earnings Per Share (EPS) 0.08
EBITDA 0.17
Effective Tax Rate (%) 23.52
Particulars MAR 2024 (Values in Cr)
Revenue 5.42
Operating Expense 5.37
Net Profit 0.04
Net Profit Margin (%) 0.73
Earnings Per Share (EPS) 0.03
EBITDA 0.05
Effective Tax Rate (%) 20.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.22
Operating Expense 0.25
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA 0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 5.79
Operating Expense 5.74
Net Profit 0.08
Net Profit Margin (%) 1.38
Earnings Per Share (EPS) 0.07
EBITDA 0.11
Effective Tax Rate (%) 18.18
Particulars MAR 2023 (Values in Cr)
Revenue 0.17
Operating Expense 0.55
Net Profit 0.04
Net Profit Margin (%) 23.52
Earnings Per Share (EPS) 0.08
EBITDA 0.06
Effective Tax Rate (%) 16.66
Particulars MAR 2022 (Values in Cr)
Revenue 0.02
Operating Expense 0.07
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.01
Operating Expense 0.12
Net Profit -0.11
Net Profit Margin (%) -1100.00
Earnings Per Share (EPS) -0.22
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 0.01
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 5.01
ROE % 0.62
ROCE % 0.76
Total Debt to Total Equity 0.08
EBITDA Margin 1.90
Particulars MAR 2023 (Values in Cr)
Book Value / Share -1.71
ROE % 1.08
ROCE % 1.14
Total Debt to Total Equity 0.00
EBITDA Margin 35.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.80
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -1.80
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -1100.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share -1.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.91
Total Assets 8.68
Total Liabilities 8.68
Total Equity 8.54
Share Outstanding 11306500
Price to Book Ratio 1.99
Return on Assets (%) 0.95
Return on Capital (%) 0.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 0.30
Total Liabilities 0.30
Total Equity -0.83
Share Outstanding 4899000
Price to Book Ratio -4.58
Return on Assets (%) 13.53
Return on Capital (%) -17.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.06
Total Liabilities 0.06
Total Equity -0.87
Share Outstanding 4899000
Price to Book Ratio 0.00
Return on Assets (%) 3.41
Return on Capital (%) -1.53
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.01
Total Liabilities 0.01
Total Equity -0.88
Share Outstanding 4899000
Price to Book Ratio 0.00
Return on Assets (%) -599.51
Return on Capital (%) 55.72
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 0.01
Total Liabilities 0.01
Total Equity -0.77
Share Outstanding 4899000
Price to Book Ratio 0.00
Return on Assets (%) 1.55
Return on Capital (%) -0.12
Particulars MAR 2024 (Values in Cr)
Net Income 0.10
Cash from Operations -6.00
Cash from Investing 0.00
Cash from Financing 8.88
Net change in Cash 2.85
Free Cash Flow -6.00
Particulars MAR 2023 (Values in Cr)
Net Income 0.05
Cash from Operations 0.06
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.05
Free Cash Flow 0.06
Particulars MAR 2022 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2021 (Values in Cr)
Net Income -0.10
Cash from Operations -0.10
Cash from Investing 0.00
Cash from Financing 0.10
Net change in Cash 0.00
Free Cash Flow -0.10
Particulars MAR 2020 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

GUJARAT INJECT (KERALA) LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
20.98 -3.54 redarrow
red-green-graph indicator
13 Bearish
3 Bullish
  • 5 Days 21.20
  • 26 Days 23.60
  • 10 Days 21.80
  • 50 Days 24.50
  • 12 Days 22.10
  • 100 Days 23.50
  • 20 Days 23.10
  • 200 Days 20.30
21.71 PIVOT

First Support

20.53

First Resistance

22.92

Second Support

19.32

Second Resistance

24.10

Third Support

18.14

Third Resistance

25.31

RSI

35.91

ADX

41.43

MACD

-1.52

Williams % R

-75.22

Commodity Channel Index (CCI)

-78.91

Date

2025-04-30

Week

32448.00

Same Day

2991.00

Month

15278.00

1 Year

-0.19

3 Year

0.20

Over 1 Month

-18.83%

down

Over 1 Year

31.20%

down

Over 3 Months

-18.36%

down

Over 3 Years

105.14%

down

Over 6 Months

19.00%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

GUJARAT INJECT (KERALA) LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
100.0%
Promoter Holdings
0.0%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category

News

Left Arrow
Right Arrow

GUJARAT INJECT (KERALA) LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

GUJARAT INJECT (KERALA) LTD. Share Price

Gujarat Inject Kerala Limited was incorporated in Jan.' 91. In 2004-05, Company started production of I.V. FIuids in April, 2005.

Parent organization Joint Sector-Kerala
NSE symbol [-]
Founded 1991
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Gujarat Inject (Kerala) Ltd?

Answer Field

The share price of Gujarat Inject (Kerala) Ltd for NSE is ₹ 0.00 and for BSE is ₹ 20.98.

What is the Market Cap of Gujarat Inject (Kerala) Ltd?

Answer Field

The market cap of Gujarat Inject (Kerala) Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 30.70 Cr. as of now.

What is the 52 Week High and Low of Gujarat Inject (Kerala) Ltd?

Answer Field

The 52 Week High and Low of Gujarat Inject (Kerala) Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 29.00 and ₹ 13.11.

How to Buy Gujarat Inject (Kerala) Ltd share?

Answer Field

You can trade in Gujarat Inject (Kerala) Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Gujarat Inject (Kerala) Ltd?

Answer Field

The 1 year returns on the stock has been 31.20%.

What is the Current Share Price of Gujarat Inject (Kerala) Ltd?

Answer Field

Gujarat Inject (Kerala) Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 20.98 as on Apr 30 2025 03:16 PM.

What is the Market Cap of Gujarat Inject (Kerala) Ltd Share?

Answer Field

The market cap of Gujarat Inject (Kerala) Ltd for NSE ₹ 0.0 & for BSE ₹ 30.70 as on Apr 30 2025 03:16 PM.

What is the P/E Ratio of Gujarat Inject (Kerala) Ltd Share?

Answer Field

As on Apr 30 2025 03:16 PM the price-to-earnings (PE) ratio for Gujarat Inject (Kerala) Ltd share is 31.31.

What is the PB ratio of Gujarat Inject (Kerala) Ltd Share?

Answer Field

As on Apr 30 2025 03:16 PM, the price-to-book (PB) ratio for Gujarat Inject (Kerala) Ltd share is 6.65.

How to Buy Gujarat Inject (Kerala) Ltd Share?

Answer Field

You can trade in Gujarat Inject (Kerala) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gujarat Inject (Kerala) Ltd Share on Bajaj Broking App?

Answer Field

To buy Gujarat Inject (Kerala) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gujarat Inject (Kerala) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|